MedTrace Logo

Study of Gut Microbiome and Colorectal Tumors

NCT03297996 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2017-09-29

No results posted yet for this study

Summary

Gut microbiota were assessed in 540 colonoscopy-screened adults by 16S rRNA gene sequencing of stool samples. Investigators compared gut microbiota diversity, overall composition, and normalized taxon abundance among these groups.

Conditions

Interventions

DIAGNOSTIC_TEST

Mobio PowerSoil DNA Isolation Kit

16S rRNA amplicons covering variable regions V3 to V4 were generated using primers (347F-5'GGAGGCAGCAGTRRGGAAT'-3' and 803R 5'-CTACCRGGGTATCTAATCC-3') incorporating Roche 454 FLX Titanium adapters (Branford, CT) and a sample barcode sequence

Sponsors & Collaborators

Principal Investigators

  • Jiyoung Ahn, MD · NYU Langone Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-23
Primary Completion
2015-04-25
Completion
2015-04-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03297996 on ClinicalTrials.gov